AUTM Newsbrief
Feb. 23, 2012

Startup to develop antidote to cyanide poisoning
R&D Magazine
Cyanide poisoning is often fatal and typically affects victims of industrial accidents, terrorist attacks or structural fires. Based on research conducted at the Center for Drug Design at the University of Minnesota, startup Vytacera Pharma Inc. will develop and market Sulfanegen, a treatment for cyanide poisoning. Sulfanegen could be administered by first responders in the case of a mass casualty emergency, or to victims of smoke inhalation from a house fire.More

Tuberculosis research technology
Medical Xpress
According to the World Health Organization, one-third of the world's population is currently infected with tuberculosis bacteria. The bacteria is incredibly resistant to treatment, and despite its prevalence, very little is known about why it is so stress tolerant. But, researchers at the University of Pittsburgh have been developing a new way of culturing tuberculosis bacteria, which could lead to new insights and treatments.More

OGT signs deal for commercialization of colorectal cancer biomarker test
Oxford Gene Technology announced that it has entered into an exclusive licensing agreement with Inven2, the University of Oslo, and the technology transfer office at Oslo University, for 12 promising colorectal cancer tissue biomarkers. Colorectal cancer is the second most common cancer in women, and the 3rd most common cancer in men. The prognosis for patients is much improved if this form of cancer is detected at an early stage. Early detection and prevention of colorectal cancer through screening has caused an unprecedented reduction in incidence and death rates.More

Sigma Life Science gains rights to iPSC technology from iPS Academia Japan
Genetic Engineering & Biotechnology News
Sigma Life Science obtained a worldwide license to Kyoto University's induced pluripotent stem cell patent portfolio in return for a license fee paid to iPS Academia Japan. The Sigma-Aldrich biological product and services business is already exploiting a zinc finger protein platform and stem cell technology portfolio. The company says the licensed technology will enable it to develop new tools for drug discovery and preclinical research, including iPSCs, iPSC-derived primary cells, assays, custom cell lines and ADME/Tox services.More

Battery startup Aquion Energy gears up for production
Grid battery startup Aquion Energy announced that it plans to build a factory in Pennsylvania and begin production of its sodium batteries starting in 2013. The company — backed by Kleiner Perkins, Foundation Capital, Advanced Technology Ventures and the Department of Energy — is using basic materials like sodium and water to build modular batteries that will be able to provide energy storage services for the power grid. Aquion Energy says it's leasing a facility from the Regional Industrial Development Corporation in Westmoreland County, Pa., and the company plans to start building out the factory infrastructure soon. Battery production will start in 2013, and the factory will create 400 jobs by the end of 2015, says the company.More

New nanotechnology converts heat into power when it's needed most
Never get stranded with a dead cellphone again. A promising new technology called Power Felt, a thermoelectric device that converts body heat into an electrical current, soon could create enough juice to make another call simply by touching it. Developed by researchers in the Center for Nanotechnology and Molecular Materials at Wake Forest University, Power Felt is comprised of tiny carbon nanotubes locked up in flexible plastic fibers and made to feel like fabric. The technology uses temperature differences — room temperature versus body temperature, for instance — to create a charge. Their research appears in the current issue of Nano Letters, a leading journal in nanotechnology.More

Titan Medical collaborates with Columbia University for advanced robotic surgical technology
Titan Medical declared that it has signed a license deal with Columbia University for an innovative single port robotic surgery system known as the Insertable Robotic Effector Platform. As per the terms of the agreement, the company has been granted the rights to further upgrade and commercialize the IREP's intellectual property developed by Dr. Nabil Simaan. IREP is the smallest system that enables single port surgery. It is capable of penetrating the body ensuring complete manipulation capabilities and imaging feedback. It includes an advanced endoscope and two versatile arms, all within one lumen. Single port surgery is conducted in various areas like trans-vaginal access, trans-anal access, trans-oral access and single port gallbladder surgery. More

Scientists cook up 1-atom transistor, 12-atom magnetic storage
Daily Tech
Two impressive discoveries were reported over the last week that illustrate that while optical die-shrinks may be getting long in the tooth, circuit technology may have a ways to go before reaching intrinsic atom-scale barriers. The first discovery was announced by the University of New South Wales' Center for Quantum Computer Technology and Purdue University, who claim to have made substantial progress in the commercialization of 1-atom transistors. While not the first 1-atom transistor observed, the group claims it is the first to create the tiny picometer transistor purposefully and reliably, allowing verifiable results, versus past accidental discoveries.More

AUTM launches GTP: Web-based resource to accelerate industry licensing and commercialization of university technologies
AUTM launched a dynamic new Web-based resource to facilitate networking, partnership and licensing deals among corporations and universities. AUTM's new Global Technology Portal accelerates how universities and corporations are able to match available cutting-edge technologies with emerging market needs.More

AUTM Annual Meeting only 3 weeks away
Featuring a dynamic format, nonstop deal-making opportunities and world-class education, the AUTM 2012 Annual Meeting takes place March 14-17 at the Anaheim Marriott, Anaheim, Calif., USA. Register onsite in Anaheim.More